Inetagugene geperpavec

戈合依塔基

Report date: 2024/09/19 13:54:11

Base Information

Drug NameInetagugene geperpavec

Drug Alias NameKB-105

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Herpes simplex virus vector > HSV-1 vector

Mechanisms of ActionProtein-glutamine gamma-glutamyltransferase K gene transference

TargetsProtein-glutamine gamma-glutamyltransferase K

Therapy Area/IndicationsIchthyosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesKrystal Biotech Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsIchthyosis

Inactive IndicationsN/A

ATC CodeN/A